Mandate

Vinge advises in Studentbostäder i Sverige AB’s issuance of sustainable bonds

Vinge advises in Studentbostäder i Sverige AB’s (the “Company”) issuance of a new senior unsecured sustainability bonds in an amount of SEK 500,000,000 within a framework amount of SEK 1,000,000,000 (the “Bonds”).

In connection with the transaction the Company established a sustainability bond framework in accordance with the 2018 ICMA Sustainability Bond Guidelines. The sustainability bond framework has been evaluated by an independent third party, ISS ESG, which assessed the framework and the related policy documents and reporting standards. The sustainability framework supports, among others, the UN’s global sustainable development goals; no. 7 “affordable and clean energy”, no. 11 “sustainable cities and communities” and no. 13 “climate action”.

In accordance with the terms and conditions, the Bonds are intended to be listed on the sustainable bond list of Nasdaq Stockholm. Nordea Bank Abp, Pareto Securities AB and Swedbank AB (publ) acted as joint bookrunners and arrangers in connection with the issuance of the Bonds.

Vinge’s team consisted of Mikael Ståhl, Lionardo Ojeda and Felix Möller (Banking and Finance) as well as Clara Sohlberg and David Bokliden (Capital Markets and Public M&A).

 

Related

Vinge advises OsteoCentric on the public offer for Integrum

OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025